Brokerages Set Asante Solutions Inc (PUMP) PT at $23.38

Shares of Asante Solutions Inc (NASDAQ:PUMP) have earned an average rating of “Buy” from the twenty-one ratings firms that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and nineteen have given a buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $23.38.

Several equities research analysts have weighed in on PUMP shares. BidaskClub downgraded Asante Solutions from a “strong-buy” rating to a “buy” rating in a report on Thursday, April 25th. Bank of America restated a “neutral” rating on shares of Asante Solutions in a report on Tuesday, April 16th. Raymond James downgraded Asante Solutions from a “strong-buy” rating to an “outperform” rating and set a $25.00 price target on the stock. in a report on Thursday, April 4th. They noted that the move was a valuation call. Wells Fargo & Co started coverage on Asante Solutions in a report on Friday, March 29th. They set an “outperform” rating on the stock. Finally, Goldman Sachs Group started coverage on Asante Solutions in a report on Sunday, March 10th. They set a “buy” rating and a $28.00 price target on the stock.

PUMP stock opened at $22.17 on Friday. Asante Solutions has a 12-month low of $11.27 and a 12-month high of $25.38.

Asante Solutions (NASDAQ:PUMP) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.67 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.60 by $0.07. The firm had revenue of $546.20 million during the quarter, compared to analysts’ expectations of $519.39 million. Asante Solutions’s quarterly revenue was up 41.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.42 EPS.

In other Asante Solutions news, Director Spencer D. Armour III sold 22,500 shares of the stock in a transaction that occurred on Wednesday, April 17th. The stock was sold at an average price of $23.96, for a total transaction of $539,100.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Spencer D. Armour III sold 67,500 shares of the stock in a transaction that occurred on Wednesday, February 13th. The stock was sold at an average price of $17.15, for a total value of $1,157,625.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 112,500 shares of company stock valued at $2,129,625.

Institutional investors have recently bought and sold shares of the business. Bank of New York Mellon Corp raised its stake in shares of Asante Solutions by 2.2% during the 3rd quarter. Bank of New York Mellon Corp now owns 993,842 shares of the company’s stock worth $16,389,000 after buying an additional 21,605 shares in the last quarter. MetLife Investment Advisors LLC raised its stake in shares of Asante Solutions by 55.2% during the 3rd quarter. MetLife Investment Advisors LLC now owns 51,882 shares of the company’s stock worth $856,000 after buying an additional 18,443 shares in the last quarter. Teachers Advisors LLC raised its stake in shares of Asante Solutions by 607.8% during the 3rd quarter. Teachers Advisors LLC now owns 879,103 shares of the company’s stock worth $14,496,000 after buying an additional 754,908 shares in the last quarter. Marshall Wace North America L.P. purchased a new position in shares of Asante Solutions during the 3rd quarter worth approximately $4,451,000. Finally, Meeder Asset Management Inc. purchased a new position in shares of Asante Solutions during the 4th quarter worth approximately $171,000.

Asante Solutions Company Profile

Asante Solutions, Inc is a medical device company. The Company is a manufacturer of Asante Snap Insulin Pump System (Snap system), which is a pump featuring a modular design with pre-filled insulin cartridges and disposable pump bodies, utilized in combination with a controller. The Snap system comprises four components: the Snap system controller, a disposable pump body, disposable pre-filled insulin cartridges and disposable infusion sets.

Further Reading: How analysts view the yield curve

Analyst Recommendations for Asante Solutions (NASDAQ:PUMP)

Receive News & Ratings for Asante Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asante Solutions and related companies with MarketBeat.com's FREE daily email newsletter.